Gilead Sciences Competitors and Similar CompaniesClear all

Gilead Sciences's competitors and similar companies include Novo Nordisk, Catalent, Biogen, ViiV Healthcare, Bristol Myers Squibb and AbbVie.
Gilead Sciences
Gilead Sciences
Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines.
Novo Nordisk
Novo Nordisk
Novo Nordisk is a healthcare company that designs and manufactures pharmaceutical products.
Catalent
Catalent
Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products.
Biogen
Biogen
Biogen is a biotechnology company that discovers, develops, and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.
ViiV Healthcare
ViiV Healthcare
ViiV Healthcare is a company focused on research and development of medicines for people living with HIV.
Bristol Myers Squibb
Bristol Myers Squibb
Bristol-Myers Squibb (BMS) is a company engaged in the discovery, development, licensing, manufacturing, marketing, and distribution of biopharmaceutical products.
AbbVie
AbbVie
AbbVie is a pharmaceutical company engaged in the research and development, manufacturing, commercialization, and sale medicines and therapies.
Founding Date
Founding Date
1987
Founding Date
1923
Founding Date
2007
Founding Date
1978
Founding Date
2009
Founding Date
1887
Founding Date
2013
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Tags
Locations
Locations
Foster City, US HQ
Buenos Aires, AR
Melbourne, AU
Wien, AT
Machelen, BE
São Paulo, BR
Edmonton, CA
see more
Locations
Bagsværd, DK HQ
Tirana, AL
Boufarik, DZ
Hydra, DZ
Tizi Ouzou, DZ
Buenos Aires, AR
North Sydney, AU
see more
Locations
Somerset, US HQ
Buenos Aires, AR
Bruxelles, BE
Charleroi, BE
Charleroi, BE
Charleroi, BE
Indaiatuba, BR
see more
Locations
Cambridge, US HQ
Vicente López, AR
Macquarie Park, AU
Wien, AT
Machelen, BE
São Paul, BR
Toronto, CA
see more
Locations
London, GB HQ
Abbotsford, AU
Wavre, BE
Laval, CA
Marly Le Roi, FR
München, DE
see more
Locations
Princeton, US HQ
Mulgrave, AU
Pinewood, AU
Wien, AT
Braine L'alleud, BE
Bruxelles, BE
São Paulo, BR
see more
Locations
Lake Bluff, US HQ
Alger, DZ
Buenos Aires, AR
Mascot, AU
Wien, AT
Wavre, BE
Sarajevo, BA
see more
Employees
Employees
18,0006% increase
Employees
55,18512% increase
Employees
17,8006% decrease
Employees
9,6106% increase
Employees
1,7861% increase
Employees
34,1001% decrease
Employees
50,000
Valuation ($)
Valuation ($)
91 b
Valuation ($)
N/A
Valuation ($)
10.5 b
Valuation ($)
32.2 b
Valuation ($)
N/A
Valuation ($)
103.1 b
Valuation ($)
316.2 b
Twitter followers
Twitter followers
73.8 k
Twitter followers
45.8 k
Twitter followers
19 k
Twitter followers
45.7 k
Twitter followers
20.4 k
Twitter followers
156.9 k
Twitter followers
78.9 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
22
Number of tweets (last 30 days)
25
Number of tweets (last 30 days)
116
Number of tweets (last 30 days)
20
Number of tweets (last 30 days)
18
Number of tweets (last 30 days)
16
Number of tweets (last 30 days)
52
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
48.1
Average likes per tweet (last 30 days)
0.9
Average likes per tweet (last 30 days)
0.4
Average likes per tweet (last 30 days)
4.6
Average likes per tweet (last 30 days)
6.3
Average likes per tweet (last 30 days)
6.4
Average likes per tweet (last 30 days)
5.2
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
16%
Percentage of tweets with engagement (last 30 days)
33.62%
Percentage of tweets with engagement (last 30 days)
95%
Percentage of tweets with engagement (last 30 days)
88.89%
Percentage of tweets with engagement (last 30 days)
93.75%
Percentage of tweets with engagement (last 30 days)
88.46%
Employee Rating
Employee Rating
3.8
Employee Rating
4.2
Employee Rating
3.5
Employee Rating
4
Employee Rating
3.7
Employee Rating
3.9
Employee Rating
3.9

Financial

Revenue (est.)
Revenue (est.)
$27.1b (FY, 2023)
Revenue (est.)
kr232.3b (FY, 2023)
Revenue (est.)
$4.3b (FY, 2023)
Revenue (est.)
$9.8b (FY, 2023)
Revenue (est.)
N/A
Revenue (est.)
$45b (FY, 2023)
Revenue (est.)
$54.3b (FY, 2023)
Cost of goods
Cost of goods
$6.5b (FY, 2023)
Cost of goods
kr30.8b (FY, 2023)
Cost of goods
$3.2b (FY, 2023)
Cost of goods
$2.5b (FY, 2023)
Cost of goods
N/A
Cost of goods
$10.7b (FY, 2023)
Cost of goods
$20.4b (FY, 2023)
Gross profit
Gross profit
$20.6b (FY, 2023)
Gross profit
kr202b (FY, 2023)
Gross profit
$1b (FY, 2023)
Gross profit
$7.3b (FY, 2023)
Gross profit
N/A
Gross profit
$34.3b (FY, 2023)
Gross profit
$33.9b (FY, 2023)
Net income
Net income
$5.6b (FY, 2023)
Net income
kr83.7b (FY, 2023)
Net income
($256m) (FY, 2023)
Net income
$1.2b (FY, 2023)
Net income
N/A
Net income
$8b (FY, 2023)
Net income
$4.9b (FY, 2023)

Operating

Countries
Countries
35 (FY, 2021)
Countries
N/A
Countries
80 (FY, 2023)
Countries
N/A
Countries
N/A
Countries
N/A
Countries
70 (FY, 2022)
Manufacturing Facilities
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
8 (FY, 2021)
Manufacturing Facilities
19 (FY, 2022)
Phase I Trials Products (Oncology)
Phase I Trials Products (Oncology)
7 (FY, 2019)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
20 (FY, 2021)
Phase I Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
Phase II Trials Products (Oncology)
1 (FY, 2021)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
15 (FY, 2021)
Phase II Trials Products (Oncology)
N/A
Phase III Trials Products
Phase III Trials Products
9 (FY, 2021)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
9 (Q2, 2022)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products (Oncology)
Phase III Trials Products (Oncology)
4 (FY, 2021)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
7 (FY, 2021)
Phase III Trials Products (Oncology)
N/A
Products
Products
21 (FY, 2021)
Products
N/A
Products
8 k (FY, 2023)
Products
N/A
Products
N/A
Products
N/A
Products
N/A
Research and Development Centers
Research and Development Centers
N/A
Research and Development Centers
N/A
Research and Development Centers
N/A
Research and Development Centers
N/A
Research and Development Centers
N/A
Research and Development Centers
11 (FY, 2021)
Research and Development Centers
14 (FY, 2020)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 650m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 15.5m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Novo Nordisk
HQ
Bagsværd, DK
Employees
55,185↑ 12% increase

Novo Nordisk is a healthcare company that designs and manufactures pharmaceutical products.

View company
Catalent
HQ
Somerset, US
Employees
17,800↓ 6% decrease

Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products.

View company
Biogen
HQ
Cambridge, US
Employees
9,610↑ 6% increase

Biogen is a biotechnology company that discovers, develops, and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.

View company
ViiV Healthcare
HQ
London, GB

ViiV Healthcare is a company focused on research and development of medicines for people living with HIV.

View company